Advanced High Throughput Automated Immunoassay Fecal Occult Blood Test FIT System Receives FDA Clearance
Polymedco, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the OC-Sensor Diana, a high throughput automated system for the immunoassay fecal occult blood test (FIT) used for detecting gastrointestinal bleeding associated with disorders such as colorectal cancer, polyps and colitis. The new OC-Sensor Diana system measures 280 FIT samples per hour and ensures that quality data is consistently collected. In addition, its compact design, only 24.8" by 22" by 22" and 133 lbs., is ideal for workstation set-up. "If detected early, colorectal cancer deaths are preventable, " said Drew Cervasio, President of Polymedco.
In a study to be presented at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting™ in Chicago, researchers unveiled findings that demonstrate a link between the birth defect gastroschisis and the agricultural chemical atrazine. Gastroschisis is a type of inherited congenital abdominal wall defect in which the intestines, and sometimes other organs, develop outside the fetal abdomen through an opening in the abdominal wall. The incidence of gastroschisis is on the rise, increasing two to four times in the last 30 years. Researchers at the University of Washington (Seattle), were alerted to a higher than normal number of cases in Eastern Washington which caused them to hypothesize that the increased incidence could be due to environmental exposures in that area.
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical. Although the screening rates in the target population of adults over age 50, have increased from 20-30 percent in 1997 to nearly 55 percent in 2008--the rates are still too low. An NIH state-of-the-science panel was convened this week to identify ways to further increase the use and quality of colorectal cancer screening in the United States.
The number of Americans buying prescription drugs to treat digestive conditions climbed over 50 percent, rising from 18.1 million to 29 million people between 1997 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. Total annual spending for these drugs increased from $7 billion to nearly $19 billion from from 1997 to 2007 ( in 2007 dollars). Other findings include: - The proportion of children ages 17 and younger who had at least one prescription drug for a digestive condition purchased rose from 1.5 percent to 2.5 percent. This trend held true for seniors - increasing from 18.6 percent to 26.
The involvement of healthy volunteers (HV) in clinical and preclinical research, especially in gastroenterology, has grown dramatically over the past few years. However, many issues of ethical, methodological or even legal concerns have not been systematically studied. A research article published on January 28, 2010 in the World Journal of Gastroenterology addresses this problem. A research team lead by Professor Peter Malfertheiner, evaluated prospectively the changes in quality of life (QOL) in ten HV during a long-term endoscopy-based study. The study was conducted strictly according to existing ethical recommendations and guidelines.
Diabetes mellitus is one of the most common chronic disease of the world and the prevalence of diabetes mellitus is over 10% in Taiwan. Gastroparesis is reported in 5% to 12% of diabetic patients. Superior mesenteric artery (SMA) syndrome is an uncommon disease resulting compression of the third portion of the duodenum from the superior mesenteric artery. However, SMA syndrome can cause the same symptoms as diabetic gastroparesis. A research team, led by Dr. Wen-Ming Wang from Kaohsiung Medical University Hospital reported a rare etiology of superior mesenteric artery syndrome. Their study was published on December 21, 2009 in the World Journal of Gastroenterology.